TitleAssociate Professor
InstitutionMD Anderson
DepartmentEndocrine Neoplasia & HD
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lagan? M, Balderrama-Brondani V, Herrera KR, Chahla B, Yaylaci F, Bassett RL, Jimenez C, Varghese J, Waguespack SG, Campbell MT, Shah AY, Rojas Hernandez CM, Habra MA. Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis. Oncologist. 2024 Jul 05; 29(7):575-580. PMID: 38776552.
      Citations:    Fields:    
    2. Chahla B, Pal K, Balderrama-Brondani V, Yaylaci F, Campbell MT, Sheth RA, Habra MA. Clinical outcomes of image-guided therapies in patients with adrenocortical carcinoma: a tertiary referral center retrospective study. Oncologist. 2024 Jun 13. PMID: 38869364.
      Citations:    Fields:    
    3. Jonasch D, Habibollahi P, Kyle Jones A, Avritscher R, Habra MA, Perrier ND, Graham PH, Huang SY. Pre-procedural and intra-procedural computerized tomography: providing a roadmap for successful adrenal venous sampling procedures. Abdom Radiol (NY). 2024 May 13. PMID: 38740580.
      Citations:    Fields:    
    4. Goodkin DA, Failor RA, Habra MA. Paraneoplastic Vitiligo Associated With Adrenocortical Carcinoma. JCEM Case Rep. 2024 May; 2(5):luae070. PMID: 38707658; PMCID: PMC11066913.
    5. Al-Ward R, Brondani VB, Sawani S, Potter CL, Xu G, Waguespack SG, Varghese J, Habra MA, Lu Y, Jimenez C. High-Specific-Activity 131 I-MIBG for the Treatment of Advanced Pheochromocytoma and Paraganglioma. Clin Nucl Med. 2024 Jul 01; 49(7):610-620. PMID: 38630996.
      Citations:    Fields:    Translation:Humans
    6. Jimenez C, Habra MA, Campbell MT, Tamsen G, Cruz-Goldberg D, Long J, Bassett R, Dantzer R, Balderrama-Brondani V, Varghese J, Lu Y. Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial. Lancet Oncol. 2024 May; 25(5):658-667. PMID: 38608693.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    7. Campbell MT, Balderrama-Brondani V, Jimenez C, Tamsen G, Marcal LP, Varghese J, Shah AY, Long JP, Zhang M, Ochieng J, Haymaker C, Habra MA. Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial. Lancet Oncol. 2024 May; 25(5):649-657. PMID: 38608694.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    8. Sada A, Foster TR, Al-Ward R, Sawani S, Charchar H, Pishdad R, Ben-Shlomo A, Dy BM, Lyden ML, Bergsland E, Jasim S, Raj N, Shank JB, Hamidi O, Hamrahian AH, Chamb? JL, Srougi V, Fragoso MC, Graham PH, Habra MA, Bancos I, McKenzie TJ. The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center study. Surgery. 2024 01; 175(1):80-89. PMID: 37945477.
      Citations: 1     Fields:    Translation:Humans
    9. Balderrama-Brondani V, Griffin AM, Owen TJ, Merriman KW, Chahla BB, Varghese J, Jimenez C, Waguespack SG, Graham PH, Perrier ND, Fisher SB, Karam JA, Shah AY, Campbell M, Hassan MM, Habra MA. Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry. Endocr Pract. 2024 Jan; 30(1):25-30. PMID: 37858722.
      Citations:    Fields:    Translation:Humans
    10. Jimenez C, Ma J, Roman Gonzalez A, Varghese J, Zhang M, Perrier N, Habra MA, Graham P, Waguespack SG. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab. 2023 04 13; 108(5):1132-1142. PMID: 36433823.
      Citations:    Fields:    Translation:Humans
    11. Qdaisat A, Bedrose S, Ezzeldin O, Moawad AW, Yeung SJ, Elsayes KM, Habra MA. The prevalence and spectrum of reported incidental adrenal abnormalities in abdominal computed tomography of cancer patients: The experience of a comprehensive cancer center. Front Endocrinol (Lausanne). 2022; 13:1023220. PMID: 36457558; PMCID: PMC9706394.
      Citations:    Fields:    Translation:Humans
    12. Sarvestani AL, Gregory SN, Teke ME, Terzolo M, Berruti A, Hernandez JM, Habra MA. Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1-3 Adrenocortical Cancer After Surgery. Ann Surg Oncol. 2023 02; 30(2):680-682. PMID: 36305989.
      Citations:    Fields:    
    13. Al-Ward R, Zsembery C, Habra MA. Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options. Endocr Oncol. 2022 Jan; 2(1):R90-R101. PMID: 37435451; PMCID: PMC10259337.
      Citations: 2     
    14. Habra MA, Srougi V, Villares Fragoso MCB. Response to Letter to the Editor From de Ponthaud et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival." J Clin Endocrinol Metab. 2022 07 14; 107(8):e3540. PMID: 35188202.
      Citations:    Fields:    Translation:Humans
    15. Murvelashvili N, Polanco PM, Khorsand SM, Marrero JA, Jia L, Mirfakhraee S, Else T, Habra MA, Cole S, Hamidi O. Severe Cholestatic Jaundice (Stauffer Syndrome) as a Rare Paraneoplastic Manifestation in Adrenocortical Carcinoma. J Endocr Soc. 2022 Aug 01; 6(8):bvac101. PMID: 35811575; PMCID: PMC9261502.
    16. Shirali AS, Zagzag J, Chiang YJ, Huang H, Zhang M, Habra MA, Grubbs EG, Fisher SB, Perrier ND, Lee JE, Graham PH. Differences in Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas. Ann Surg Oncol. 2022 Sep; 29(9):5555-5563. PMID: 35499784.
      Citations:    Fields:    
    17. Daher M, Varghese J, Gruschkus SK, Jimenez C, Waguespack SG, Bedrose S, Altameemi L, Bazerbashi H, Naing A, Subaiah V, Campbell MT, Shah AY, Zhang M, Sheth RA, Karam JA, Wood CG, Perrier ND, Graham PH, Lee JE, Habra MA. Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience. J Clin Endocrinol Metab. 2022 04 19; 107(5):1239-1246. PMID: 35092681; PMCID: PMC9016449.
      Citations:    Fields:    Translation:Humans
    18. Landry JP, Clemente-Gutierrez U, Pieterman CRC, Chiang YJ, Waguespack SG, Jimenez C, Habra MA, Halperin DM, Fisher SB, Graham PH, Perrier ND. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome. Surgery. 2022 08; 172(2):559-566. PMID: 35437162; PMCID: PMC9681028.
      Citations:    Fields:    Translation:Humans
    19. Bancos I, Daher M, Lee JE, Graham PH, Karam JA, Henriquez A, Mckenzie TJ, Sada A, Vaidya A, Abbondanza T, Kiernan CM, Rao SN, Hamidi O, Sachithanandan N, Habra MA, Srougi V, Bourdeau I, Poirier J, Hoff AO, Chambo JL, Almeida MQ, Fragoso MCBV. Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival. J Clin Endocrinol Metab. 2022 03 24; 107(4):964-971. PMID: 34850915; PMCID: PMC9122637.
      Citations:    Fields:    Translation:Humans
    20. Jimenez C, Armaiz-Pena G, Dahia PLM, Lu Y, Toledo RA, Varghese J, Habra MA. Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? Cancers (Basel). 2022 Jan 18; 14(3). PMID: 35158739; PMCID: PMC8833823.
      Citations: 1     
    21. Guccione J, Soliman M, Zhang M, Habra MA, Collins K, Zhao J, Elsayes KM. Imaging characteristics of pathologically proven adrenal adenomas with myelolipomatous degeneration: correlation with clinical and pathologic features. Br J Radiol. 2022 Jan 01; 95(1129):20210555. PMID: 34623887; PMCID: PMC8722239.
      Citations:    Fields:    Translation:Humans
    22. Bedrose S, Berruti A, Terzolo M, Dekkers OM, Habra MA, Kimpel O, Megerle F, Kroiss M, Mai K, Fassnacht M. Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study. Br J Cancer. 2021 10; 125(9):1233-1238. PMID: 34400803; PMCID: PMC8548516.
      Citations: 1     Fields:    Translation:Humans
    23. Greenstein AE, Habra MA, Wadekar SA, Grauer A. Adrenal tumors provide insight into the role of cortisol in NK cell activity. Endocr Relat Cancer. 2021 06 29; 28(8):583-592. PMID: 34086600.
      Citations: 1     Fields:    Translation:HumansCells
    24. Moawad AW, Ahmed A, Fuentes DT, Hazle JD, Habra MA, Elsayes KM. Machine learning-based texture analysis for differentiation of radiologically indeterminate small adrenal tumors on adrenal protocol CT scans. Abdom Radiol (NY). 2021 10; 46(10):4853-4863. PMID: 34085089.
      Citations: 1     Fields:    Translation:Humans
    25. Nguyen H, Shah K, Waguespack SG, Hu MI, Habra MA, Cabanillas ME, Busaidy NL, Bassett R, Zhou S, Iyer PC, Simmons G, Kaya D, Pitteloud M, Subudhi SK, Diab A, Dadu R. Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns. Endocr Relat Cancer. 2021 06 02; 28(7):419-431. PMID: 33890870; PMCID: PMC8183642.
      Citations: 4     Fields:    Translation:Humans
    26. Pegna GJ, Roper N, Kaplan RN, Bergsland E, Kiseljak-Vassiliades K, Habra MA, Pommier Y, Del Rivero J. The Immunotherapy Landscape in Adrenocortical Cancer. Cancers (Basel). 2021 May 28; 13(11). PMID: 34071333; PMCID: PMC8199088.
      Citations: 3     
    27. Taylor MH, Takahashi S, Capdevila J, Tahara M, Leboulleux S, Kiyota N, Dutcus CE, Xie R, Robinson B, Sherman S, Habra MA, Elisei R, Wirth LJ. Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib. Thyroid. 2021 08; 31(8):1226-1234. PMID: 33637020; PMCID: PMC8377516.
      Citations: 7     Fields:    Translation:HumansCells
    28. Kiseljak-Vassiliades K, Bancos I, Hamrahian A, Habra M, Vaidya A, Levine AC, Else T. American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach. Endocr Pract. 2020 Nov; 26(11):1366-1383. PMID: 33875173; PMCID: PMC8058447.
      Citations: 4     Fields:    Translation:Humans
    29. Daher M, Habra MA. Visual Vignette. Endocr Pract. 2020 Dec; 26(12):1524. PMID: 33471745.
      Citations:    Fields:    Translation:Humans
    30. Chortis V, Arlt W, Ronchi CL, Laurent C, Petit JM, Casasnovas O, Habra MA, Kanji A, Salvatori R, Ho ATN, Villa D, Limvorapitak W, Majidi F, Martino S, Kondakci M, Antke C, Haase M, Fassnacht M, Spyroglou A, Beuschlein F, Wahlin BE, Gimm O, Rudelius M, Schott M, Germing U, Haas R, Gattermann N. Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study. Eur J Endocrinol. 2020 10; 183(4):453-462. PMID: 32567556.
      Citations: 6     Fields:    Translation:Humans
    31. Jimenez C, Subbiah V, Stephen B, Ma J, Milton D, Xu M, Zarifa A, Akhmedzhanov FO, Tsimberidou A, Habra MA, Rodon Anhert J, Fu S, Naing A. Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas. Cancers (Basel). 2020 Aug 16; 12(8). PMID: 32824391; PMCID: PMC7465458.
      Citations: 10     
    32. Bedrose S, Miller KC, Altameemi L, Ali MS, Nassar S, Garg N, Daher M, Eaton KD, Yorio JT, Daniel DB, Campbell M, Bible KC, Ryder M, Chintakuntlawar AV, Habra MA. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. J Immunother Cancer. 2020 07; 8(2). PMID: 32737143; PMCID: PMC7394183.
      Citations: 9     Fields:    Translation:Humans
    33. Jimenez C, Habra MA, Kroiss M, Megerle F, Kurlbaum M, Zimmermann S, Wendler J, Lapa C, Quinkler M, Scherf-Clavel O, Fassnacht M. Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib. J Clin Endocrinol Metab. 2020 05 01; 105(5). PMID: 31900481; PMCID: PMC8204945.
      Citations: 7     Fields:    Translation:Humans
    34. Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck. 2020 06; 42(6):1325-1328. PMID: 32437031; PMCID: PMC7262055.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    35. Ahmed AA, Thomas AJ, Ganeshan DM, Blair KJ, Lall C, Lee JT, Morshid AI, Habra MA, Elsayes KM. Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management. Abdom Radiol (NY). 2020 04; 45(4):945-963. PMID: 31894378.
      Citations: 9     Fields:    Translation:Humans
    36. Elbanan MG, Javadi S, Ganeshan D, Habra MA, Rao Korivi B, Faria SC, Elsayes KM. Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics. Abdom Radiol (NY). 2020 04; 45(4):905-916. PMID: 31529204.
      Citations: 5     Fields:    Translation:Humans
    37. Morani AC, Jensen CT, Habra MA, Agrons MM, Menias CO, Wagner-Bartak NA, Shaaban AM, Roman-Colon AM, Elsayes KM. Adrenocortical hyperplasia: a review of clinical presentation and imaging. Abdom Radiol (NY). 2020 04; 45(4):917-927. PMID: 31093730.
      Citations: 3     Fields:    Translation:Humans
    38. Naing A, Meric-Bernstam F, Stephen B, Karp DD, Hajjar J, Rodon Ahnert J, Piha-Paul SA, Colen RR, Jimenez C, Raghav KP, Ferrarotto R, Tu SM, Campbell M, Wang L, Sabir SH, Tapia C, Bernatchez C, Frumovitz M, Tannir N, Ravi V, Khan S, Painter JM, Abonofal A, Gong J, Alshawa A, McQuinn LM, Xu M, Ahmed S, Subbiah V, Hong DS, Pant S, Yap TA, Tsimberidou AM, Dumbrava EEI, Janku F, Fu S, Simon RM, Hess KR, Varadhachary GR, Habra MA. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1). PMID: 32188704; PMCID: PMC7078933.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    39. Bedrose S, Daher M, Altameemi L, Habra MA. Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions. Cancers (Basel). 2020 Feb 22; 12(2). PMID: 32098326; PMCID: PMC7072549.
      Citations: 9     
    40. Fisher SB, Habra MA, Chiang YJ, Wu SY, Graham PH, Grubbs EG, Lee JE, Perrier ND. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Manual for Adrenocortical Carcinoma. World J Surg. 2020 02; 44(2):544-551. PMID: 31493191.
      Citations:    Fields:    Translation:Humans
    41. Smith DC, Kebebew E, Habra MA, Chugh R, Schneider BJ, Jafarinasabian P, Ijzerman MM, Lin VH, Mohideen P, Naing A, Kroiss M, Fassnacht M. A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma. Invest New Drugs. 2020 10; 38(5):1421-1429. PMID: 31984451.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    42. Habra MA, Stephen B, Campbell M, Hess K, Tapia C, Xu M, Rodon Ahnert J, Jimenez C, Lee JE, Perrier ND, Boraddus RR, Pant S, Subbiah V, Hong DS, Zarifa A, Fu S, Karp DD, Meric-Bernstam F, Naing A. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer. 2019 09 18; 7(1):253. PMID: 31533818; PMCID: PMC6751592.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    43. Habra MA, Sukkari MA, Hasan A, Albousen Y, Elsheshtawi MA, Jimenez C, Campbell M, Karam JA, Graham PH, Hatia RI, Phan AT, Varghese J, Hassan MM. Epidemiological risk factors for adrenocortical carcinoma: A hospital-based case-control study. Int J Cancer. 2020 04 01; 146(7):1836-1840. PMID: 31241762.
      Citations: 4     Fields:    Translation:Humans
    44. Wannachalee T, Turcu AF, Bancos I, Habra MA, Avram AM, Chuang HH, Waguespack SG, Auchus RJ. The Clinical Impact of [68 Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone - Secreting Tumours. Clin Endocrinol (Oxf). 2019 08; 91(2):288-294. PMID: 31066920; PMCID: PMC6689243.
      Citations: 11     Fields:    Translation:Humans
    45. Berruti A, Ettaieb H, Sukkari MA, Feelders RA, Grisanti S, Mazziotti G, Sigala S, Baudin E, Haak H, Habra MA, Terzolo M, Lib? R, Lagan? M, Bertherat J, Cartry J. Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study. Eur J Endocrinol. 2019 May 01; 180(5):311-320. PMID: 30970324.
      Citations: 8     Fields:    Translation:Humans
    46. Jasim S, Habra MA. Management of Adrenocortical Carcinoma. Curr Oncol Rep. 2019 02 23; 21(3):20. PMID: 30798468.
      Citations: 25     Fields:    Translation:Humans
    47. Thomas AJ, Habra MA, Bhosale PR, Qayyum AA, Ahmed K, Vicens R, Elsayes KM. Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography. Abdom Radiol (NY). 2018 11; 43(11):3101-3108. PMID: 29671009.
      Citations: 3     Fields:    Translation:Humans
    48. Iyer PC, Dadu R, Gule-Monroe M, Busaidy NL, Ferrarotto R, Habra MA, Zafereo M, Williams MD, Gunn GB, Grosu H, Skinner HD, Sturgis EM, Gross N, Cabanillas ME. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J Immunother Cancer. 2018 07 11; 6(1):68. PMID: 29996921; PMCID: PMC6042271.
      Citations: 64     Fields:    Translation:Humans
    49. Wirth LJ, Tahara M, Robinson B, Francis S, Brose MS, Habra MA, Newbold K, Kiyota N, Dutcus CE, Mathias E, Guo M, Sherman SI, Schlumberger M. Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT). Cancer. 2018 06 01; 124(11):2365-2372. PMID: 29656442.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    50. Iyer PC, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Zafereo M, Gross N, Hess KR, Gule-Monroe M, Williams MD, Cabanillas ME. Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid. 2018 01; 28(1):79-87. PMID: 29161986; PMCID: PMC6425981.
      Citations: 37     Fields:    Translation:Humans
    51. Whitsett TG, Aronova A, Henderson SA, LoBello J, Habra MA, Grubbs EG, Lee JE, Sircar K, Zarnegar R, Scognamiglio T, Fahey TJ, Perrier ND, Demeure MJ, Romero Arenas MA. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma. Ann Surg Oncol. 2018 Mar; 25(3):801-807. PMID: 29218429.
      Citations: 16     Fields:    Translation:Humans
    52. Cote GJ, Evers C, Hu MI, Grubbs EG, Williams MD, Hai T, Duose DY, Houston MR, Bui JH, Mehrotra M, Waguespack SG, Busaidy NL, Cabanillas ME, Habra MA, Luthra R, Sherman SI. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma. J Clin Endocrinol Metab. 2017 09 01; 102(9):3591-3599. PMID: 28911154; PMCID: PMC5587058.
      Citations: 22     Fields:    Translation:Humans
    53. Michelle M A, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, Roman-Colon AM, Elsayes KM. Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics. Br J Radiol. 2017 Nov; 90(1079):20170330. PMID: 28707538; PMCID: PMC5963387.
      Citations: 4     Fields:    Translation:Humans
    54. Wagner-Bartak NA, Baiomy A, Habra MA, Mukhi SV, Morani AC, Korivi BR, Waguespack SG, Elsayes KM. Cushing Syndrome: Diagnostic Workup and Imaging Features, With Clinical and Pathologic Correlation. AJR Am J Roentgenol. 2017 Jul; 209(1):19-32. PMID: 28639924.
      Citations: 12     Fields:    Translation:Humans
    55. Varghese J, Habra MA. Update on adrenocortical carcinoma management and future directions. Curr Opin Endocrinol Diabetes Obes. 2017 Jun; 24(3):208-214. PMID: 28277340.
      Citations: 23     Fields:    Translation:HumansCells
    56. Mathiesen JS, Habra MA, Bassett JHD, Choudhury SM, Balasubramanian SP, Howlett TA, Robinson BG, Vestergaard P, Frank-Raue K, Gimenez-Roqueplo AP, Castinetti F. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study. J Clin Endocrinol Metab. 2017 06 01; 102(6):2069-2074. PMID: 28323957.
      Citations: 10     Fields:    Translation:Humans
    57. Tahara M, Schlumberger M, Elisei R, Habra MA, Kiyota N, Paschke R, Dutcus CE, Hihara T, McGrath S, Matijevic M, Kadowaki T, Funahashi Y, Sherman SI. Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid. Eur J Cancer. 2017 04; 75:213-221. PMID: 28237867.
      Citations: 23     Fields:    Translation:HumansCellsCTClinical Trials
    58. Xu JY, Murphy WA, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, Sherman SI, Hu MI, Milton DR. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab. 2016 12; 101(12):4871-4877. PMID: 27662441; PMCID: PMC5155685.
      Citations: 7     Fields:    Translation:Humans
    59. Bilen MA, Patel A, Hess KR, Munoz J, Busaidy NL, Wheler JJ, Janku F, Falchook GS, Hong DS, Meric-Bernstam F, Habra MA, Naing A. Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials. Cancer Chemother Pharmacol. 2016 07; 78(1):167-71. PMID: 27286994.
      Citations: 3     Fields:    Translation:Humans
    60. Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Else T, Knijnenburg TA, Ciriello G, Kim S, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Gill AJ, Sidhu SB, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Wheeler DA, Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW, Lerario AM, Assie G, Beuschlein F, Almeida MQ, Fragoso MCBV, Bertherat J, Fassnacht M. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016 05 09; 29(5):723-736. PMID: 27165744; PMCID: PMC4864952.
      Citations: 204     Fields:    Translation:HumansCells
    61. Thomas AZ, Blute ML, Seitz C, Habra MA, Karam JA. Management of the Incidental Adrenal Mass. Eur Urol Focus. 2016 Feb; 1(3):223-230. PMID: 28723391.
      Citations: 6     Fields:    
    62. Rao SN, Habra MA. 5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications. Horm Cancer. 2016 Feb; 7(1):17-23. PMID: 26660146; PMCID: PMC10355959.
      Citations:    Fields:    Translation:Humans
    63. Cabanillas ME, Habra MA. Lenvatinib: Role in thyroid cancer and other solid tumors. Cancer Treat Rev. 2016 Jan; 42:47-55. PMID: 26678514.
      Citations: 64     Fields:    Translation:HumansAnimalsCells
    64. Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO. Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma. J Hepatocell Carcinoma. 2015; 2:131-42. PMID: 27508202; PMCID: PMC4918293.
      Citations: 7     
    65. Dadu R, Hu MI, Cleeland C, Busaidy NL, Habra M, Waguespack SG, Sherman SI, Ying A, Fox P, Cabanillas ME. Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer-Related Diarrhea and Its Effects on Quality of Life: A Pilot Study. Thyroid. 2015 Oct; 25(10):1085-90. PMID: 26200040; PMCID: PMC4589264.
      Citations: 10     Fields:    Translation:Humans
    66. Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG, Hai T, Jimenez C, Cote GJ, Ozsari L, Hofmann MC, Zheng S, Verhaak R, Pagliaro L, Cortez MA, Lee MH, Yeung SC, Habra MA. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Res. 2015 Oct 01; 75(19):4131-42. PMID: 26282167; PMCID: PMC4592476.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    67. Ozsari L, Kutahyalioglu M, Elsayes KM, Vicens RA, Sircar K, Jazaerly T, Waguespack SG, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Vassilopoulou-Sellin R, Jimenez C, Lee JE, Habra MA. Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis. Endocrine. 2016 Feb; 51(2):351-9. PMID: 26206754.
      Citations: 8     Fields:    Translation:Humans
    68. Altinmakas E, Guo M, Kundu UR, Habra MA, Ng C. Computed tomography and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings in adrenal candidiasis and histoplasmosis: two cases. Clin Imaging. 2015 Nov-Dec; 39(6):1115-8. PMID: 26298420.
      Citations: 1     Fields:    Translation:Humans
    69. Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, Shiang C, Grabiner B, Blonska M, Skerl S, Shao Y, Cody D, Delacerda J, Kingsley C, Webb D, Carlock C, Zhou Z, Hsieh YC, Lee J, Elliott A, Ramirez M, Bankson J, Hazle J, Wang Y, Li L, Weng S, Rizk N, Wen YY, Lin X, Wang H, Wang H, Zhang A, Xia X, Wu Y, Habra M, Yang W, Pusztai L, Yeung SC, Lee MH. The cell cycle regulator 14-3-3s opposes and reverses cancer metabolic reprogramming. Nat Commun. 2015 Jul 16; 6:7530. PMID: 26179207; PMCID: PMC4507299.
      Citations: 39     Fields:    Translation:HumansCells
      Citations: 12     Fields:    Translation:Humans
    71. Vodopivec DM, Habra MA, Ng C, Sircar K, Grubbs EG. Visual Vignette. Endocr Pract. 2015 Jul; 21(7):854. PMID: 26121444.
      Citations:    Fields:    Translation:Humans
    72. Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, Dutcus CE, Zhu J, Sherman SI, de las Heras B. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015 Feb 12; 372(7):621-30. PMID: 25671254.
      Citations: 516     Fields:    Translation:HumansCTClinical Trials
    73. Wassal EY, Habra MA, Vicens R, Rao P, Elsayes KM. Ovarian thecal metaplasia of the adrenal gland in association with Beckwith-Wiedemann syndrome. World J Radiol. 2014 Dec 28; 6(12):919-23. PMID: 25550997; PMCID: PMC4278153.
      Citations: 1     
    74. Jasim S, Ozsari L, Habra MA. Multikinase inhibitors use in differentiated thyroid carcinoma. Biologics. 2014; 8:281-91. PMID: 25506209; PMCID: PMC4260520.
      Citations: 13     
    75. Shawa H, Elsayes KM, Javadi S, Sircar K, Jimenez C, Habra MA. Clinical and radiologic features of pheochromocytoma/ganglioneuroma composite tumors: a case series with comparative analysis. Endocr Pract. 2014 Sep; 20(9):864-9. PMID: 24641930.
      Citations: 8     Fields:    
    76. Takeuchi S, Balachandran A, Habra MA, Phan AT, Bassett RL, Macapinlac HA, Chuang HH. Impact of ?8F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients. Eur J Nucl Med Mol Imaging. 2014 Nov; 41(11):2066-73. PMID: 24990404.
      Citations: 12     Fields:    Translation:Humans
    77. Baudin E, Habra MA, Deschamps F, Cote G, Dumont F, Cabanillas M, Arfi-Roufe J, Berdelou A, Moon B, Al Ghuzlan A, Patel S, Leboulleux S, Jimenez C. Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma. Eur J Endocrinol. 2014 Sep; 171(3):R111-22. PMID: 24891137.
      Citations: 42     Fields:    Translation:HumansAnimals
    78. Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. World J Surg. 2014 Jun; 38(6):1318-27. PMID: 24615603.
      Citations: 8     Fields:    Translation:Humans
    79. Dadu R, Waguespack SG, Sherman SI, Hu MI, Busaidy NL, Jimenez C, Habra MA, Ying AK, Bassett RL, Cabanillas ME. Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer. Oncologist. 2014 May; 19(5):477-82. PMID: 24733667; PMCID: PMC4012968.
      Citations: 12     Fields:    Translation:Humans
    80. Dadu R, Devine C, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas ME. Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib. J Clin Endocrinol Metab. 2014 Jun; 99(6):2086-94. PMID: 24628550; PMCID: PMC4037722.
      Citations: 35     Fields:    Translation:Humans
    81. Shawa H, Deniz F, Bazerbashi H, Hernandez M, Vassilopoulou-Sellin R, Jimenez C, Habra MA. Mitotane-induced hyperlipidemia: a retrospective cohort study. Int J Endocrinol. 2013; 2013:624962. PMID: 24348556; PMCID: PMC3848058.
      Citations: 5     
    82. Ayala-Ramirez M, Jasim S, Feng L, Ejaz S, Deniz F, Busaidy N, Waguespack SG, Naing A, Sircar K, Wood CG, Pagliaro L, Jimenez C, Vassilopoulou-Sellin R, Habra MA. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol. 2013 Dec; 169(6):891-899. PMID: 24086089; PMCID: PMC4441210.
      Citations: 90     Fields:    Translation:Humans
    83. Shawa H, Elsayes KM, Javadi S, Morani A, Williams MD, Lee JE, Waguespack SG, Busaidy NL, Vassilopoulou-Sellin R, Jimenez C, Habra MA. Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre. Clin Endocrinol (Oxf). 2014 Mar; 80(3):342-7. PMID: 24033606.
      Citations: 22     Fields:    Translation:Humans
    84. Thosani S, Ayala-Ramirez M, Palmer L, Hu MI, Rich T, Gagel RF, Cote G, Waguespack SG, Habra MA, Jimenez C. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 2013 Nov; 98(11):E1813-9. PMID: 24030942; PMCID: PMC5399523.
      Citations: 26     Fields:    Translation:Humans
    85. Hajjar J, Habra MA, Naing A. Metformin: an old drug with new potential. Expert Opin Investig Drugs. 2013 Dec; 22(12):1511-7. PMID: 23978196.
      Citations: 14     Fields:    Translation:HumansAnimals
    86. Jimenez C, Rohren E, Habra MA, Rich T, Jimenez P, Ayala-Ramirez M, Baudin E. Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma. Curr Oncol Rep. 2013 Aug; 15(4):356-71. PMID: 23674235.
      Citations: 64     Fields:    Translation:Humans
    87. Ejaz S, Shawa H, Henderson SA, Habra MA. Melanoma of unknown primary origin presenting as a rapidly enlarging adrenal mass. BMJ Case Rep. 2013 Jun 19; 2013. PMID: 23784764; PMCID: PMC3703057.
      Citations: 2     Fields:    Translation:Humans
    88. Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc. 2013 Nov; 27(11):4026-32. PMID: 23765427.
      Citations: 37     Fields:    Translation:Humans
    89. Shawa H, Busaidy NL, Schellingerhout D, Habra MA. Unilateral renal artery stenosis with renal atrophy in a patient with metastatic papillary thyroid carcinoma treated with sorafenib. BMJ Case Rep. 2013 May 15; 2013. PMID: 23682094; PMCID: PMC3670046.
      Citations:    Fields:    Translation:Humans
    90. Ayala-Ramirez M, Palmer JL, Hofmann MC, de la Cruz M, Moon BS, Waguespack SG, Habra MA, Jimenez C. Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma. J Clin Endocrinol Metab. 2013 Apr; 98(4):1492-7. PMID: 23436918; PMCID: PMC5393459.
      Citations: 37     Fields:    Translation:Humans
    91. Carhill AA, Cabanillas ME, Jimenez C, Waguespack SG, Habra MA, Hu M, Ying A, Vassilopoulou-Sellin R, Gagel RF, Sherman SI, Busaidy NL. The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring. J Clin Endocrinol Metab. 2013 Jan; 98(1):31-42. PMID: 23185034; PMCID: PMC3537108.
      Citations: 30     Fields:    Translation:Humans
    92. Habra MA, Ejaz S, Feng L, Das P, Deniz F, Grubbs EG, Phan A, Waguespack SG, Ayala-Ramirez M, Jimenez C, Perrier ND, Lee JE, Vassilopoulou-Sellin R. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab. 2013 Jan; 98(1):192-7. PMID: 23150683; PMCID: PMC3537094.
      Citations: 29     Fields:    Translation:Humans
    93. Ayala-Ramirez M, Chougnet CN, Habra MA, Palmer JL, Leboulleux S, Cabanillas ME, Caramella C, Anderson P, Al Ghuzlan A, Waguespack SG, Baudin E, Jimenez C, Deandreis D. Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas. J Clin Endocrinol Metab. 2012 Nov; 97(11):4040-50. PMID: 22965939; PMCID: PMC3683800.
      Citations: 64     Fields:    Translation:Humans
    94. Chuang HH, Deniz F, Sircar K, Jimenez C, Rubin De Celis C, Wood CG, Habra MA. [?8F]Fluorodeoxyglucose positron emission tomography-guided therapy in metastatic adrenocortical carcinoma: an illustrative case. J Clin Oncol. 2012 Sep 10; 30(26):e246-9. PMID: 22649135; PMCID: PMC3434990.
      Citations: 1     Fields:    Translation:Humans
    95. Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer. 2012 Jun 01; 118(11):2804-12. PMID: 22006217; PMCID: PMC3882190.
      Citations: 43     Fields:    Translation:Humans
    96. Yeung SC, Habra MA, Thosani SN. Lung cancer-induced paraneoplastic syndromes. Curr Opin Pulm Med. 2011 Jul; 17(4):260-8. PMID: 21577115.
      Citations: 10     Fields:    Translation:Humans
    97. Shahani S, Ahmad A, Barakat FH, Chuang HH, Fowler NH, Myers JN, Stava C, Habra MA. F-18 FDG PET/CT detecting thyroid plasmacytoma after the successful treatment of gastric large B-cell lymphoma. Clin Nucl Med. 2011 Apr; 36(4):317-9. PMID: 21368613.
      Citations: 2     Fields:    Translation:Humans
    98. Khan MI, Waguespack SG, Habra MA, Broaddus R, Jimenez C. Acute-onset ectopic adrenocorticotropic hormone syndrome secondary to metastatic endometrioid carcinoma of the ovaries as a fatal complication. J Clin Oncol. 2011 Jun 01; 29(16):e462-4. PMID: 21422435.
      Citations: 1     Fields:    Translation:Humans
    99. Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara M, Habra MA. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer. 2011 Oct 01; 117(19):4381-9. PMID: 21412758; PMCID: PMC3134535.
      Citations: 58     Fields:    Translation:HumansCTClinical Trials
    100. Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011 Mar; 96(3):717-25. PMID: 21190975.
      Citations: 138     Fields:    Translation:Humans
    101. Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid. 2011 Feb; 21(2):189-92. PMID: 21186952; PMCID: PMC3025175.
      Citations: 21     Fields:    Translation:Humans
    102. Ayala-Ramirez M, Habra MA, Busaidy N, Cote G, Rich T, Waguespack S, Jimenez C. A catecholamine crisis on Mount Kilimanjaro: a hypoxia effect? J Travel Med. 2010 Nov-Dec; 17(6):424-6. PMID: 21050326.
      Citations: 2     Fields:    Translation:Humans
    103. Habra MA, Chuang H, Ayala-Ramirez M, Rich T, Kyle K, Jimenez C, N??ez R. Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging. Endocrine. 2010 Feb; 37(1):209-12. PMID: 20963572.
      Citations: 6     Fields:    Translation:Humans
    104. Habra MA, Jimenez C, Huang SC, Cote GJ, Murphy WA, Gagel RF, Hoff AO. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia. Endocr Pract. 2008 Dec; 14(9):1108-14. PMID: 19158050.
      Citations: 10     Fields:    Translation:HumansCells
    105. Habra MA, Weaver EJ, Prewitt PV. Primary cutaneous large B-cell lymphoma of the leg and acute hypercalcemia. J Clin Oncol. 2007 Dec 20; 25(36):5825-6. PMID: 18089880.
      Citations: 1     Fields:    Translation:Humans
    106. Habra MA, Vassilopoulou-Sellin R. Contribution of routine chest x-ray in the long-term follow-up of patients with differentiated thyroid carcinoma. Thyroid. 2006 Mar; 16(3):303-6. PMID: 16571094.
      Citations:    Fields:    Translation:Humans
    107. Habra MA, Feig BW, Waguespack SG. Image in endocrinology: adrenal pseudocyst. J Clin Endocrinol Metab. 2005 May; 90(5):3067-8. PMID: 15872337.
      Citations: 2     Fields:    Translation:Humans
    108. Habra MA, Vassilopoulou-Sellin R. Cervical spine metastasis mimicking thyroid bed uptake in follicular thyroid carcinoma. Thyroid. 2005 Mar; 15(3):298-9. PMID: 15785252.
      Citations: 1     Fields:    Translation:Humans
    109. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004 Aug; 26(8):716-26. PMID: 15287039.
      Citations: 69     Fields:    Translation:Humans
    110. Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J Clin Endocrinol Metab. 2004 Aug; 89(8):4142-5. PMID: 15292360.
      Citations: 4     Fields:    Translation:Humans
    111. Habra MA, Hijazi R, Verstovsek G, Marcelli M. Medullary thyroid carcinoma associated with hyperthyroidism: a case report and review of the literature. Thyroid. 2004 May; 14(5):391-6. PMID: 15186618.
      Citations: 5     Fields:    Translation:Humans
    112. Mitotane-induced hyperlipidemia. International Journal of Endocrinology. 2013.
    113. Targets by organ site.
    114. Erratum. Cancer Cell. 30:363.
    115. Thyroid cancer survivorship management. 241-253.
    116. Insulinoma in a marathon runner illustrating the effects of exercise on insulin sensitivity and glucose homeostasis. Endocrinologist. 16:20-24.
    117. Melanoma of unknown primary origin presenting as a rapidly enlarging adrenal mass. BMJ Case Reports.
    118. Nature Communications. 6.
    119. Bone metastases and skeletal-related events in medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism. 101:4871-4877.
    120. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Research. 75:4131-4142.
    121. Efficacy of the natural clay, calcium aluminosilicate anti-diarrheal, in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life. Thyroid. 25:1085-1090.
    122. Endocrinologic issues. 343-360.
    123. Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials. Cancer Chemotherapy and Pharmacology. 78:167-171.
    124. Management of the Incidental Adrenal Mass. European Urology Focus. 1:223-230.
    125. Preexisting adrenal masses in patients with adrenocortical carcinoma. Endocrine.
    126. Efficacy and tolerability of vemurafenib in patients with BRAFV600E positive papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism. 100:E77-E81.
    127. The prevalence and impact of hyperglycemia and hyperlipidemia in patients with advanced cancer receiving combination treatmentwith themammalian target of rapamycin inhibitor temsirolimus and insulin growth factor-receptor antibody cixutumumab. Oncologist. 20:737-741.
    128. 5th International ACC Symposium. Hormones and Cancer. 7:17-23.
    129. Multikinase inhibitors use in differentiated thyroid carcinoma. Biologics: Targets and Therapy. 8:281-291.
    130. Clinical and radiologic features of pheochromocytoma/ganglioneuroma composite tumors. Endocrine Practice. 20:864-869.
    131. Computed tomography and <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography findings in adrenal candidiasis and histoplasmosis. Clinical Imaging.
    132. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 29:723-736.
    HABRA's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (356)
    Co-Authors (118)
    Similar People (60)
    Same Department Expand Description